|
Q4 FY2024
As of Feb 1, 2025
|
Q3 FY2024
As of Nov 2, 2024
|
Q2 FY2024
As of Aug 3, 2024
|
Q1 FY2024
As of May 4, 2024
|
Q4 FY2023
As of Feb 3, 2024
|
Q3 FY2023
As of Oct 28, 2023
|
Q2 FY2023
As of Jul 29, 2023
|
Q1 FY2023
As of Apr 29, 2023
|
Q4 FY2022
As of Jan 28, 2023
|
Q3 FY2022
As of Oct 29, 2022
|
Q2 FY2022
As of Jul 30, 2022
|
Q1 FY2022
As of Apr 30, 2022
|
Q4 FY2021
As of Jan 29, 2022
|
Q3 FY2021
As of Oct 30, 2021
|
Q2 FY2021
As of Jul 31, 2021
|
Q1 FY2021
As of May 1, 2021
|
Q4 FY2020
As of Jan 30, 2021
|
Q3 FY2020
As of Oct 31, 2020
|
Q2 FY2020
As of Aug 1, 2020
|
Q1 FY2020
As of May 2, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Merchandise inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Land, property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Borrowings under revolving line of credit | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued salaries, wages and related benefits | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Noncurrent operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock, no par value: 1,000 shares authorized; 165.2 and 162.4 shares issued and outstanding | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive gain | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
| Accumulated depreciation |
Loading...
